Clinical trials
Completed Myositis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 59 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 6 |
| Assistance Publique - Hôpitaux de Paris | 4 |
| National Institute of Environmental Health Sciences (NIEHS) | 4 |
| Groupe Hospitalier Pitie-Salpetriere | 2 |
| Institut de Myologie, France | 2 |
| Karolinska Institutet | 2 |
| Kezar Life Sciences, Inc. | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| Rohit Aggarwal, MD | 2 |
| University of Pittsburgh | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myositis | 59 |
| Dermatomyositis | 23 |
| Polymyositis | 19 |
| Myositis, Inclusion Body | 11 |
| Muscular Diseases | 9 |
| Autoimmune Diseases | 5 |
| Arthritis, Rheumatoid | 4 |
| Connective Tissue Diseases | 4 |
| Lupus Erythematosus, Systemic | 4 |
| Muscular Dystrophies | 4 |
Trials
Showing 51 to 59 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.